Fact CheckerSign in

NCT06273735Completed

Prospective Trial: Acute Myocardial Injury After Radical Prostatectomy

Evaluation of Intra- and Postoperative Cardiac Events in Patients With Localised Prostate Carcinoma and Radical Prostatectomy

Source: ClinicalTrials.gov · Last updated 3 Feb 2026

Brief summary (registry, in English)

This prospective observational study investigates the incidence of acute myocardial injury after radical prostatectomy for prostate cancer. Consecutive patients undergoing elective open or robot-assisted radical prostatectomy at the Martini-Klinik are included. High-sensitivity cardiac troponin I (hs-cTnI) is measured preoperatively and on postoperative days 1 and 2 to identify acute myocardial injury, defined according to the 4th Universal Definition of Myocardial Infarction. Secondary outcomes include the incidence of myocardial infarction, major adverse cardiac and cerebrovascular events, and mortality during the hospital stay and at 24 months. Baseline patient characteristics (age, BMI, cardiovascular risk factors including the Revised Cardiac Risk Index, comorbidities, and prior cardiac therapy) as well as surgical and tumor-specific parameters are recorded. Associations between acute myocardial injury and clinical variables are analyzed.

Status (registry)
Completed
Study type
Observational
Enrollment
1000 (actual)
First submitted
15 Feb 2024
Start date
14 Aug 2023
Primary completion date
28 Feb 2024
Lead sponsor
Martini-Klinik am UKE GmbH
NCT number
NCT06273735

What you commit to

  • Study type: Observational
  • Participants enrolled: 1000
  • From 14 Aug 2023 to the primary completion date, 28 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • No exclusion of patients who fulfil the above inclusion criteria

Who the study is looking for

  • Consent form signed
  • Patients with a biopsy-proven prostate carcinoma
  • planned ORP or RARP

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Martini Klinik am UKE GmbH
Coordinator of this site? Confirm its status
HamburgGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.